Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bio Essence (BIOE) Shares Outstanding (2020 - 2025)

Bio Essence has reported Shares Outstanding over the past 6 years, most recently at $38.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.0% year-over-year to $38.0 million; the TTM value through Dec 2025 reached $38.0 million, changed 0.0%, while the annual FY2025 figure was $38.0 million, 0.0% changed from the prior year.
  • Shares Outstanding for Q4 2025 was $38.0 million at Bio Essence, roughly flat from $38.0 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $38.0 million in Q2 2023 and troughed at $33.0 million in Q1 2021.
  • A 5-year average of $35.8 million and a median of $38.0 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: changed 0.0% in 2021 and later rose 15.15% in 2023.
  • Year by year, Shares Outstanding stood at $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022, then rose by 15.15% to $38.0 million in 2023, then changed by 0.0% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025.
  • Business Quant data shows Shares Outstanding for BIOE at $38.0 million in Q4 2025, $38.0 million in Q3 2025, and $38.0 million in Q2 2025.